... During his presidential campaign, Trump called for the government to use its clout to negotiate Medicare drug prices, but senior administration officials said he would not call for that change — which is stridently opposed by drug companies. The New York Times is also reporting that Trump won't call for Medicare to negotiate drug prices. Because of the drug companies.”The White House said in February 2017 that Trump continued to support negotiating Medicare drug prices:Q: Is he for Medicare negotiating drug prices or not? The president's clear — I mean when you look at the cost — not just drug cost. Trump often spoke more generally about negotiating drug prices in 2017, without specifically citing Medicare.

Source: Washington Post May 11, 2018 14:48 UTC